Haemonetics (HAE) Operating Income (2016 - 2025)
Historic Operating Income for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $67.4 million.
- Haemonetics' Operating Income rose 1417.44% to $67.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $251.1 million, marking a year-over-year increase of 3916.81%. This contributed to the annual value of $221.8 million for FY2025, which is 3452.99% up from last year.
- According to the latest figures from Q4 2025, Haemonetics' Operating Income is $67.4 million, which was up 1417.44% from $58.5 million recorded in Q3 2025.
- In the past 5 years, Haemonetics' Operating Income registered a high of $71.3 million during Q1 2025, and its lowest value of -$21.2 million during Q2 2021.
- Over the past 5 years, Haemonetics' median Operating Income value was $41.5 million (recorded in 2022), while the average stood at $39.1 million.
- In the last 5 years, Haemonetics' Operating Income plummeted by 18142.04% in 2021 and then soared by 211345.32% in 2022.
- Haemonetics' Operating Income (Quarter) stood at $24.5 million in 2021, then surged by 76.58% to $43.3 million in 2022, then grew by 6.24% to $46.0 million in 2023, then increased by 28.39% to $59.0 million in 2024, then increased by 14.17% to $67.4 million in 2025.
- Its last three reported values are $67.4 million in Q4 2025, $58.5 million for Q3 2025, and $53.9 million during Q2 2025.